2. Search Result
Search Result
Results for "

Paclitaxel

" in MedChemExpress (MCE) Product Catalog:

92

Inhibitors & Agonists

2

Screening Libraries

1

Fluorescent Dye

5

Biochemical Assay Reagents

1

Peptides

3

Inhibitory Antibodies

21

Natural
Products

3

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0015
    Paclitaxel
    Maximum Cited Publications
    231 Publications Verification

    		 Microtubule/Tubulin ADC Cytotoxin Apoptosis Autophagy Cardiovascular Disease Cancer
    Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy .
    Paclitaxel
  • HY-125348
    6α-Hydroxy paclitaxel

    		Drug Metabolite Cancer
    6α-Hydroxy paclitaxel is a primary metabolite of Paclitaxel. 6α-Hydroxy paclitaxel retains a time-dependent effect on organic anion–transporting polypeptides 1B1/SLCO1B1 (OATP1B1) with similar inhibition potency to Paclitaxel, whereas it no longer showed time-dependent inhibition of OATP1B3. 6α-Hydroxy paclitaxel can be used for the research of cancer .
    6α-Hydroxy paclitaxel
  • HY-106146
    Paclitaxel ceribate

    Protaxel

    		 Microtubule/Tubulin ADC Cytotoxin Apoptosis Autophagy Cancer
    Paclitaxel ceribate is the ester form of paclitaxel, a natural antineoplastic agent that stabilizes tubulin polymerization. Paclitaxel causes mitotic arrest and induces apoptosis, ultimately leading to cell death. Paclitaxel also induces autophagy .
    Paclitaxel ceribate
  • HY-B0015R
    Paclitaxel (Standard)

    		Microtubule/Tubulin ADC Cytotoxin Apoptosis Autophagy Cancer
    Paclitaxel (Standard) is the analytical standard of Paclitaxel. This product is intended for research and analytical applications. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy .
    Paclitaxel (Standard)
  • HY-137776R
    Paclitaxel C (Standard)

    		Others Others
    Paclitaxel C (Standard) is the analytical standard of Paclitaxel C. This product is intended for research and analytical applications. Paclitaxel C is a compound that can be found in taxus cutting .
    Paclitaxel C (Standard)
  • HY-B0015S1
    Paclitaxel-d5 (benzoyloxy)

    		Microtubule/Tubulin ADC Cytotoxin Apoptosis Autophagy Cancer
    Paclitaxel-d5 (benzoyloxy) is the deuterium labeled Paclitaxel. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2].
    Paclitaxel-d5 (benzoyloxy)
  • HY-164165
    Paclitaxel-2′-succinate NHS ester

    		Others Cancer
    Paclitaxel-2′-succinate NHS ester is a paclitaxel derivative with a succinic acid linker, in which the carboxyl group is activated by the NHS ester. The NHS ester group is highly reactive toward amino or hydroxyl groups and can be used to conjugate with other molecules such as peptides, proteins, antibodies, enzymes or polymers. Paclitaxel-2′-succinate NHS ester can be used in the development of nanomedicines and in the study of cancer therapy .
    Paclitaxel-2′-succinate NHS ester
  • HY-139248
    Paclitaxel octadecanedioate

    		Others Cancer
    Paclitaxel octadecanedioate (compound PTX-FA18) is comprised of Paclitaxel (HY-B0015) conjugated to 1,18-octadecanedioic acid (HY-W005178). Paclitaxel octadecanedioate mixed with human serum albumin (HAS) is cytotoxic to HT-1080, PANC-1, HT-29 and Hela cells (IC50s = 12, 2.48, 8.62, and 64.42 nM, respectively) .
    Paclitaxel octadecanedioate
  • HY-137776
    Paclitaxel C

    Taxuyunnanine A

    		 Others Others
    Paclitaxel C is a compound that can be found in taxus cutting .
    Paclitaxel C
  • HY-164272
    2'-O-TBDMS-Paclitaxel

    		Microtubule/Tubulin Cancer
    2'-O-TBDMS-Paclitaxel is a paclitaxel (HY-B0015) derivative which 2'-OH group is protected as a tert-butyldimethylsilyl (TBDMS) ether .
    2'-O-TBDMS-Paclitaxel
  • HY-P99974
    Nab-Paclitaxel
    1 Publications Verification

    Nanoparticle albumin-bound Paclitaxel; Nanoparticle albumin-bound ABI-007

    		 Microtubule/Tubulin Apoptosis Autophagy Cancer
    Nab-Paclitaxel is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel (Paclitaxel: human albumin=1:9), in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel was associated with higher response rates and better tolerability, with favorable pharmacokinetic properties . (The product size below only indicate the effective content of Paclitaxel. The actual albumin quality depends on the batch. The ratio of each component in this product is Paclitaxel: albumin = 1:7-1:11.)
    Nab-Paclitaxel
  • HY-144149S
    3'-p-Hydroxy paclitaxel-d5

    		Isotope-Labeled Compounds Others
    3'-p-Hydroxy paclitaxel-d5 is the deuterium labeled 3'-p-Hydroxy paclitaxel[1].
    3'-p-Hydroxy paclitaxel-d5
  • HY-141147
    7-O-(Amino-PEG4)-paclitaxel

    		Drug-Linker Conjugates for ADC Cancer
    7-O-(Amino-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Amino-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs) .
    7-O-(Amino-PEG4)-paclitaxel
  • HY-125348S
    6α-Hydroxy Paclitaxel-d5

    		Isotope-Labeled Compounds Cancer
    6α-Hydroxy Paclitaxel-d5 is the deuterium labeled 6α-Hydroxy paclitaxel. 6α-Hydroxy paclitaxel is a primary metabolite of Paclitaxel. 6α-Hydroxy paclitaxel retains a time-dependent effect on organic anion–transporting polypeptides 1B1/SLCO1B1 (OATP1B1) with similar inhibition potency to Paclitaxel, whereas it no longer showed time-dependent inhibition of OATP1B3. 6α-Hydroxy paclitaxel can be used for the research of cancer[1].
    6α-Hydroxy Paclitaxel-d5
  • HY-141148
    7-O-(Cbz-N-amido-PEG4)-paclitaxel

    		Drug-Linker Conjugates for ADC Cancer
    7-O-(Cbz-N-amido-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Cbz-N-amido-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs) .
    7-O-(Cbz-N-amido-PEG4)-paclitaxel
  • HY-77572R
    7-Epi 10-desacetyl paclitaxel (Standard)

    		ADC Cytotoxin Cancer
    7-Epi 10-desacetyl paclitaxel (Standard) is the analytical standard of 7-Epi 10-desacetyl paclitaxel. This product is intended for research and analytical applications. 7-Epi 10-desacetyl paclitaxel (7-epi-10-deacetyltaxol), a taxol derivative, exhibits cytotoxicity against HeLa cells with an IC50 of 85 μM .
    7-Epi 10-desacetyl paclitaxel (Standard)
  • HY-20584
    10-Deacetyl-7-xylosyl paclitaxel

    10-Deacetyl-7-xylosyltaxol; 10-DeacetylPaclitaxel 7-Xyloside; 10-Deacetyltaxol 7-Xyloside

    		 Microtubule/Tubulin ADC Cytotoxin Cancer
    10-Deacetyl-7-xylosyl paclitaxel is a Paclitaxel (a microtubule stabilizing agent; enhances tubulin polymerization) derivative with improved pharmacological features.
    10-Deacetyl-7-xylosyl paclitaxel
  • HY-13646C
    Encequidar mesylate hydrochloride

    HM30181 mesylate hydrochloride; HM30181A mesylate hydrochloride

    		 P-glycoprotein Cancer
    Encequidar (HM30181) mesylate hydrochloride is a potent and selective inhibitor of P-glycoprotein (MDR1). Encequidar mesylate hydrochloride improves anti-tumor efficacy of Paclitaxel (HY-B0015) in mouse tumor models .
    Encequidar mesylate hydrochloride
  • HY-77572
    7-Epi 10-desacetyl paclitaxel

    7-epi-10-deacetyltaxol; 10-Deacetyl-7-epiPaclitaxel

    		 ADC Cytotoxin Cancer
    7-Epi 10-desacetyl paclitaxel (7-epi-10-deacetyltaxol), a taxol derivative, exhibits cytotoxicity against HeLa cells with an IC50 of 85 μM .
    7-Epi 10-desacetyl paclitaxel
  • HY-162161
    Flutax-2

    		Fluorescent Dye Cancer
    Flutax-2 is an active fluorescent derivative of Paclitaxel, binds to αβ-tubulin dimer polymerized. Flutax-2 can be used for imaging microtubules in live cells, isolated cytoskeletons and parasite (Ex/Em=496/526 nm) .
    Flutax-2
  • HY-132866
    YS-370

    		P-glycoprotein Cancer
    YS-370 (compound 44) is a potent, high selective, and orally active inhibitor of P-glycoprotein (P-gp). YS-370 stimulates the P-gp ATPase activity and has moderate inhibition against CYP3A4. YS-370 effectively reverses multidrug resistance (MDR) to paclitaxel and colchicine in SW620/AD300 and HEK293T-ABCB1 cells. YS-370 in combination with paclitaxel achieves much stronger antitumor activity .
    YS-370
  • HY-12929
    NSC756093

    SU093

    		 Others Cancer
    NSC756093 is a potent inhibitor of the GBP1:PIM1 interaction. NSC756093 can potentially revert resistance to paclitaxel. NSC756093 can be used for ovarian cancer research .
    NSC756093
  • HY-N7776
    7-Xylosyl-10-Deacetyltaxol B

    7-xylosyl-10-DeacetylPaclitaxel B

    		 Others Cancer
    7-Xylosyl-10-Deacetyltaxol B (7-xylosyl-10-Deacetylpaclitaxel B) is a paclitaxel derivative derived from T. cuspidate. 7-Xylosyl-10-Deacetyltaxol B has anti-tumor activity and inhibits the growth of S180 sarcoma .
    7-Xylosyl-10-Deacetyltaxol B
  • HY-N7777
    7-Xylosyl-10-Deacetyltaxol C

    7-Xylosyl-10-DeacetylPaclitaxel C

    		 Others Cancer
    7-Xylosyl-10-Deacetyltaxol C (7-Xylosyl-10-Deacetylpaclitaxel C) is a paclitaxel derivative derived from T. cuspidate. 7-Xylosyl-10-Deacetyltaxol C has anti-tumor activity and inhibits the growth of S180 sarcoma .
    7-Xylosyl-10-Deacetyltaxol C
  • HY-W019939
    Hydroxy-PEG10-Boc

    		ADC Linker Cancer
    Hydroxy-PEG10-Boc is extacted from patent CN108707228 (example 0024) . Hydroxy-PEG10-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG10-Boc can be conjugated to Paclitaxel (HY-B0015) or docetaxel (HY-B0011) .
    Hydroxy-PEG10-Boc
  • HY-150231
    SU056
    1 Publications Verification

    		 YB-1 Cancer
    SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis, and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effects of Paclitaxel (HY-B0015) .
    SU056
  • HY-150565
    P-gp inhibitor 5

    		P-glycoprotein Cancer
    P-gp inhibitor 5 is a potent P-glycoprotein (P-gp) inhibitor. P-gp inhibitor 5 has antiproliferative activity against certain cancer cell lines. P-gp inhibitor 5 is effective in reversing the multidrug resistance (MDR) phenotype in ABCB1/Flp-In TM-293 and KBvin cells by restoring their sensitivity to Vincristine (HY-N0488A) and Paclitaxel (HY-B0015) .
    P-gp inhibitor 5
  • HY-144393
    P-gp/BCRP-IN-1

    		BCRP Cancer
    P-gp/BCRP-IN-1 (compound 19) is a potential, relatively safe, orally active and efficient efflux transporter (P-gp and BCRP) inhibitor. P-gp/BCRP-IN-1 exerts resistance reversal by inhibiting the efflux function of P-gp and BCRP. P-gp/BCRP-IN-1 can overcome the resistance and improve the oral bioavailability of PTX (Paclitaxel) .
    P-gp/BCRP-IN-1
  • HY-N7256
    Dihydrocephalomannine

    		Microtubule/Tubulin Cancer
    Dihydrocephalomannine (compound 1b), an analogue of Paclitaxel, shows reduced cytotoxicity and tubulin binding compared to Paclitaxel .
    Dihydrocephalomannine
  • HY-77574
    7-xylosyltaxol

    7-XylosylPaclitaxel; Taxol-7-xyloside

    		 Microtubule/Tubulin Cancer
    7-xylosyltaxol(Taxol-7-xyloside) is a taxol (Paclitaxel) derivative; Paclitaxel binds to tubulin and inhibits the disassembly of microtubules.
    7-xylosyltaxol
  • HY-N0227
    7-epi-Taxol
    2 Publications Verification

    7-epi-Paclitaxel

    		 Microtubule/Tubulin Cancer
    7-epi-Taxol is an active metabolite of taxol, with activity comparable to that of taxol against cell replication, promoting microtubule bundle formation and against microtubule depolymerization.
    7-epi-Taxol
  • HY-16565
    10-Deacetylbaccatin III

    		Others Cancer
    10-Deacetylbaccatin-III is an intermediate in the preparation process of paclitaxel.
    10-Deacetylbaccatin III
  • HY-107629
    Flutax 1

    		Biochemical Assay Reagents Others
    Flutax 1 is a fluorescent paclitaxel derivative, which can be used for microtubule staining.
    Flutax 1
  • HY-157529
    IR820-PTX

    		Microtubule/Tubulin Fluorescent Dye Cancer
    IR820-PTX, an IR-820 (HY-136886)-Paclitaxel (HY-B0015) conjugate, is an amphipathic small molecule prodrug. IR820-PTX effectively inhibits tumor growth via combined photothermal therapy (PTT) and chemotherapy .
    IR820-PTX
  • HY-158435
    P-gp inhibitor 23

    		P-glycoprotein Cytochrome P450 Cancer
    P-gp inhibitor 23 (compound 14F) is a potent inhibitor of P-gp and CYP3A4, with the EC50 and IC50 of 28 nM and 223 nM, respectively .
    P-gp inhibitor 23
  • HY-13503
    Epothilone A

    Epo A

    		 Microtubule/Tubulin Apoptosis Cancer
    Epothilone A is a competitive inhibitor of the binding of [ 3H] paclitaxel to tubulin polymers, with a Ki of 0.6-1.4 μM.
    Epothilone A
  • HY-131010
    Flutax-2 (5/6-mixture)

    		Fluorescent Dye Microtubule/Tubulin Cancer
    Flutax-2 (5/6-mixture) is an active fluorescent derivative of paclitaxel. Flutax-2 (5/6-mixture) binds to a polymerized α,β tubulin dimer. Excitation/emission wavelength: 496/524 nm. Paclitaxel, a diterpenoid secondary metabolite produced by Taxus species, can be used for the research of a variety of cancers .
    Flutax-2 (5/6-mixture)
  • HY-W040254
    Biotin-LC-LC-NHS

    		Fluorescent Dye Others
    Biotin-LC-LC-NHS is a SMCC cross-linking reagent that can be used to mark antibody and other small molecules, such as Paclitaxel .
    Biotin-LC-LC-NHS
  • HY-137863
    Pemirolast

    		Others Inflammation/Immunology
    Pemirolast is an orally active antiallergic agent. Pemirolast attenuates paclitaxel hypersensitivity reactions, can be used for bronchial asthma and conjunctivitis research - .
    Pemirolast
  • HY-156958
    S-72

    		Microtubule/Tubulin STAT Apoptosis Inflammation/Immunology
    S-72 inhibits tubulin polymerization and further triggers mitosis-phase cell cycle arrest and cell apoptosis, in addition to suppressing STAT3 signaling .
    S-72
  • HY-140696C
    m-PEG-OH (MW 20000)

    mPEG-Hydroxy (MW 20000); Polyethylene glycol monomethyl ether (MW 20000)

    		 PROTAC Linkers Cancer
    m-PEG-OH (MW 20000) can be used as a macroinitiator to participate in the synthesis of amphiphilic block copolymers. Nanoscale micelles can be prepared by using amphiphilic block copolymers to deliver active drugs. Paclitaxel (HY-B0015), a hydrophobic anticancer agent encapsulated in micelles, has stronger activity in killing cancer cells than free Paclitaxel. And it preferentially accumulates in tumor tissue with only limited distribution in healthy organs.
    m-PEG-OH (MW 20000)
  • HY-140696D
    m-PEG-OH (MW 10000)

    mPEG-Hydroxy (MW 10000); Polyethylene glycol monomethyl ether (MW 10000)

    		 PROTAC Linkers Cancer
    m-PEG-OH (MW 10000) can be used as a macroinitiator to participate in the synthesis of amphiphilic block copolymers. Amphiphilic block copolymers can be used to prepare nanoscale micelles to deliver active drugs. Paclitaxel (HY-B0015), a hydrophobic anticancer agent encapsulated in micelles, has stronger activity in killing cancer cells than free Paclitaxel. And it preferentially accumulates in tumor tissue with only limited distribution in healthy organs.
    m-PEG-OH (MW 10000)
  • HY-140696E
    m-PEG-OH (MW 1000)

    mPEG-Hydroxy (MW 1000); Polyethylene glycol monomethyl ether (MW 1000)

    		 PROTAC Linkers Cancer
    m-PEG-OH (MW 1000) can be used as a macroinitiator to participate in the synthesis of amphiphilic block copolymers. Amphiphilic block copolymers can be used to prepare nanoscale micelles to deliver active drugs. Paclitaxel (HY-B0015), a hydrophobic anticancer agent encapsulated in micelles, has stronger cancer-killing activity than free Paclitaxel. And it accumulates preferentially in tumor tissues and has only limited distribution in healthy organs.
    m-PEG-OH (MW 1000)
  • HY-126370
    Geranylgeranyl pyrophosphate

    		Endogenous Metabolite Cancer
    Geranylgeranyl pyrophosphate is a metabolite involved in protein geranylgeranylation. Geranylgeranyl pyrophosphate is the common precursor of  diterpenoids, for example, Paclitaxel. Geranylgeranyl pyrophosphate can be used for cancer research .
    Geranylgeranyl pyrophosphate
  • HY-W035709
    Hydrocinchonine

    Dihydrocinchonine

    		 Apoptosis Cancer
    Hydrocinchonine (Dihydrocinchonine) is a multidrug resistance (MDR)-reversal agent. Hydrocinchonine exerts synergistic apoptotic effect with Paclitaxel in MES-SA/DX5 cells .
    Hydrocinchonine
  • HY-W777110
    7-(Triethylsilyl)baccatin III

    7-O-(Triethylsilyl)baccatin III

    		 Others Cancer
    7-(Triethylsilyl)baccatin III (7-O-(Triethylsilyl)baccatin III) is intermediate for preparation of the antitumor agent Paclitaxel (HY-B0015) .
    7-(Triethylsilyl)baccatin III
  • HY-155647
    Microtubule stabilizing agent-1

    		Microtubule/Tubulin Cancer
    Microtubule stabilizing agent-1 (compound 3l) is a Paclitaxel derivative that efficiently promotes tubulin polymerization. Microtubule stabilizing agent-1 shows antitumor efficacy .
    Microtubule stabilizing agent-1
  • HY-126370A
    Geranylgeranyl pyrophosphate triammonium

    		Endogenous Metabolite Cancer
    Geranylgeranyl pyrophosphate triammonium is a metabolite involved in protein geranylgeranylation. Geranylgeranyl pyrophosphate triammonium is the common precursor of  diterpenoids, for example, Paclitaxel. Geranylgeranyl pyrophosphate triammonium can be used for cancer research .
    Geranylgeranyl pyrophosphate triammonium
  • HY-16371
    Ortataxel

    IDN 5109; BAY 59-8862

    		 Microtubule/Tubulin Cancer
    Ortataxel (IDN 5109; BAY 59-8862) is a derivative of Paclitaxel (HY-B0015). Ortataxel exhibits activity against multiple drug-sensitive and resistant cancer cell lines .
    Ortataxel
  • HY-13503R
    Epothilone A (Standard)

    		Microtubule/Tubulin Apoptosis Cancer
    Epothilone A (Standard) is the analytical standard of Epothilone A. This product is intended for research and analytical applications. Epothilone A is a competitive inhibitor of the binding of [3H] paclitaxel to tubulin polymers, with a Ki of 0.6-1.4 μM.
    Epothilone A (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: